Correlation Between AT S and Vincerx Pharma,

Can any of the company-specific risk be diversified away by investing in both AT S and Vincerx Pharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AT S and Vincerx Pharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AT S Austria and Vincerx Pharma, Common, you can compare the effects of market volatilities on AT S and Vincerx Pharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AT S with a short position of Vincerx Pharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of AT S and Vincerx Pharma,.

Diversification Opportunities for AT S and Vincerx Pharma,

-0.32

Correlation Coefficient

AT S  Vincerx Pharma,

Very good diversification

The 3 months correlation between ATS and Vincerx is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding AT S Austria and Vincerx Pharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma, Common and AT S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AT S Austria are associated (or correlated) with Vincerx Pharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma, Common has no effect on the direction of AT S i.e., AT S and Vincerx Pharma, go up and down completely randomly.

Pair Corralation between AT S and Vincerx Pharma,

Assuming the 90 days trading horizon AT S Austria is expected to generate 0.31 times more return on investment than Vincerx Pharma,. However, AT S Austria is 3.18 times less risky than Vincerx Pharma,. It trades about -0.05 of its potential returns per unit of risk. Vincerx Pharma, Common is currently generating about -0.23 per unit of risk. If you would invest  1,405  in AT S Austria on January 24, 2025 and sell it today you would lose (75.00) from holding AT S Austria or give up 5.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.0%
Values	Daily Returns

AT S Austria  vs.  Vincerx Pharma, Common

AT S Austria

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in AT S Austria are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, AT S may actually be approaching a critical reversion point that can send shares even higher in May 2025.

Vincerx Pharma, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vincerx Pharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in May 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with AT S and Vincerx Pharma,

The main advantage of trading using opposite AT S and Vincerx Pharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AT S position performs unexpectedly, Vincerx Pharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma, will offset losses from the drop in Vincerx Pharma,'s long position.

The idea behind AT S Austria and Vincerx Pharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.